Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
Rank in Stocks
#4343
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Share Price
$2.43
Last synced: 2026-10-20
Market Cap
$3.63B
Change (1 day)
0.48%
Change (1 year)
-9.82%
Country
CN
Trade Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Category
Healthcare
P/E ratio for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
P/E ratio as of October 2026 TTM: 39.24
According to Zhejiang Huahai Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 39.24. At the end of 2023 the company had a P/E ratio of 25.74.
P/E ratio history for Zhejiang Huahai Pharmaceutical Co., Ltd. from 2000 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 39.24 | 69.06% |
| 2024 | 23.21 | -9.83% |
| 2023 | 25.74 | -4.86% |
| 2022 | 27.05 | -58.11% |
| 2021 | 64.57 | 22.23% |
| 2020 | 52.83 | 31.84% |
| 2019 | 40.07 | -65.53% |
| 2018 | 116.23 | 137.72% |
| 2017 | 48.90 | 8.56% |
| 2016 | 45.04 | -0.01% |
| 2015 | 45.05 | 5.37% |
| 2014 | 42.75 | 51.55% |
| 2013 | 28.21 | 56.24% |
| 2012 | 18.05 | -34.28% |
| 2011 | 27.47 | -63.06% |
| 2010 | 74.37 | 58.63% |
| 2009 | 46.88 | 92.88% |
| 2008 | 24.31 | -50.05% |
| 2007 | 48.66 | 68.07% |
| 2006 | 28.95 | 82.56% |
| 2005 | 15.86 | -22.72% |
| 2004 | 20.52 | 8.47% |
| 2003 | 18.92 | -39.33% |
| 2002 | 31.19 | -15.78% |
| 2001 | 37.03 | -19.39% |
| 2000 | 45.93 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 34.96 | -10.91% |
IN
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.